Market capitalization | $2.93m |
Enterprise Value | $-1.95m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 0.32 |
EV/Sales (TTM) EV/Sales | -0.07 |
P/S ratio (TTM) P/S ratio | 0.11 |
P/B ratio (TTM) P/B ratio | 0.25 |
Revenue growth (TTM) Revenue growth | -22.33% |
Revenue (TTM) Revenue | $26.73m |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
Mar '24 |
+/-
%
|
||
Revenue | 27 27 |
22%
22%
|
|
Gross Profit | 7.31 7.31 |
48%
48%
|
|
EBITDA | -4.92 -4.92 |
48%
48%
|
EBIT (Operating Income) EBIT | -5.42 -5.42 |
46%
46%
|
Net Profit | -19 -19 |
66%
66%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Universe Pharmaceuticals, Inc. manufactures, markets, and distributes traditional derivative products. It also sells biomedical drugs, medical instruments, traditional and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on December 12, 1998 and is headquartered in Ji'an, China.
Head office | Cayman Islands |
CEO | Gang Lai |
Employees | 225 |
Founded | 1998 |
Website | www.universe-pharmacy.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.